Cholinergic Antagonists Combined with Electrical Stimulation or Bladder Training Treatments for Overactive Bladder in Female Adults: A Meta-Analysis of Randomized Controlled Trials

[1] Stewart WF(2003)Prevalence and burden of overactive bladder in the United States World K Urol. 20 327-336

[2] Van Rooyen JB(2005)Overactive bladder: epidemiology and social impact Curr Opin Obstet Gynecol. 17 507-511

[3] Cundiff GW(2011)Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients Curr Urol Rep. 12 351-357

[4] Abrams P(2016)Nonantimuscarinic treatment for overactive bladder: a systematic review Am J Obstet Gynecol. 41 878-883

[5] Herzog AR(2012)Overactive bladder syndrome:management and treatment options Aust Fam Phys. 24 5-13

[6] Corey R(2013)Treatment of overactive bladder: what is on the horizon? Int Urogynecol J. 41 208-214

[7] Tubaro A(2015)Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder Turkish J Urol. 14 457-464

[8] Palleschi G(2013)Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training Curr Urol Rep. 11 1800-1805

[9] Pagoria D(2014)Combination of sacral neuromodulation and tolterodine for treatment of idiopathic overactive bladder in women: a clinical trial Urol J. 28 867-869

[10] O’Connor RC(2012)Clinical effects of tolterodine with pelvic floor electrical stimulation in the treatment of female OAB patients Clin Med China. 26 729-732

[1] Stewart WF(2003)Prevalence and burden of overactive bladder in the United States World K Urol. 20 327-336

[2] Van Rooyen JB(2005)Overactive bladder: epidemiology and social impact Curr Opin Obstet Gynecol. 17 507-511

[3] Cundiff GW(2011)Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients Curr Urol Rep. 12 351-357

[4] Abrams P(2016)Nonantimuscarinic treatment for overactive bladder: a systematic review Am J Obstet Gynecol. 41 878-883

[5] Herzog AR(2012)Overactive bladder syndrome:management and treatment options Aust Fam Phys. 24 5-13

[6] Corey R(2013)Treatment of overactive bladder: what is on the horizon? Int Urogynecol J. 41 208-214

[7] Tubaro A(2015)Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder Turkish J Urol. 14 457-464

[8] Palleschi G(2013)Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training Curr Urol Rep. 11 1800-1805

[9] Pagoria D(2014)Combination of sacral neuromodulation and tolterodine for treatment of idiopathic overactive bladder in women: a clinical trial Urol J. 28 867-869

[10] O’Connor RC(2012)Clinical effects of tolterodine with pelvic floor electrical stimulation in the treatment of female OAB patients Clin Med China. 26 729-732